Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.
about
Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyPhase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant gliomaPhase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyTrabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsPhase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro.Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study.Camptothecin-based regimens for treatment of ewing sarcoma: past studies and future directionsSuccessful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin.Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.Repair of topoisomerase I-mediated DNA damage.Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase IThe impact of base excision DNA repair in age-related neurodegenerative diseasesp53 stimulates human topoisomerase I activity by modulating its DNA binding.
P2860
Q26795742-B884AA1F-41D0-402C-956A-79687765C613Q27851478-6FCB676F-3B05-411D-BD5B-B73C8AEA6248Q33382930-92240CB6-AA7F-4504-B36B-EC6BF51398CEQ33384269-377FABBF-766A-432E-AF49-970EC96CE5C3Q33409117-A4FA41D1-AEA8-456D-9D78-451EFF4EA207Q33649056-E83447DE-7D4D-430E-B091-4FC650DD2511Q33713587-50D7B636-D858-4950-82E9-346C57216B47Q33875792-89B68A96-56DC-46D7-8D29-E324DB73C06CQ34397019-F2C6B0D0-CA27-4ECE-B46D-D0EC6636F0A9Q34679179-3ECA5BBF-BB19-4801-849F-178AC8F275EDQ34787772-68617128-78A3-4099-9529-D09985890385Q35688335-F45CA4ED-34C8-4EAA-8C71-6455A4049F89Q35800735-19227527-5B20-45A0-A5B2-0B203430D6CCQ36557533-2F259F7C-596C-4BED-A39E-3E8671DA78BBQ36711144-1904454F-0ED1-4296-B8A4-837D0EF31BCBQ38563230-9AB120AB-1099-4BF5-A56F-9B2E770CCA15Q40240820-4D10A755-BA78-4A32-9A78-88E2CDA8D642
P2860
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Topoisomerase I-mediated cytot ...... ase I by the O6-methylguanine.
@ast
Topoisomerase I-mediated cytot ...... ase I by the O6-methylguanine.
@en
type
label
Topoisomerase I-mediated cytot ...... ase I by the O6-methylguanine.
@ast
Topoisomerase I-mediated cytot ...... ase I by the O6-methylguanine.
@en
prefLabel
Topoisomerase I-mediated cytot ...... ase I by the O6-methylguanine.
@ast
Topoisomerase I-mediated cytot ...... ase I by the O6-methylguanine.
@en
P2093
P1433
P1476
Topoisomerase I-mediated cytot ...... rase I by the O6-methylguanine
@en
P2093
Loktionova NA
Pourquier P
Waltman JL
P407
P577
2001-01-01T00:00:00Z